Analytical instrumentation specialist Shimadzu has introduced LabSolutions MD software that supports analytical method development for high-performance liquid chromatography (HPLC). The software offers established method scouting functionality and supports automated column and solvent screening. Shimadzu reports that LabSolutions MD offers swift identification of ideal separation conditions using design of experiments (DoE). The company reports that the…
ProMed Pharma begins preclinical testing of resorbable contraceptive implant
After receiving funding from the Bill & Melinda Gates Foundation, ProMed Pharma has begun preclinical evaluation of a novel fully resorbable contraceptive implant. The Plymouth, Minnesota–based company imagines that the contraceptive implants could ultimately find use in low- and middle-income (LMIC) settings. The novel implant potentially could offer women 18 months of contraception through the…
The Center for Inquiry sues homeopathy company Boiron over alleged consumer deception
The nonprofit organization Center for Inquiry (CFI) is suing Boiron, one of the biggest manufacturers of homeopathic products. In a lawsuit invoking the District of Columbia Consumer Protection Procedures Act, CFI argues that Boiron sells scores of materially identical products composed of sugar pills and powders while claiming that the products treat or cure a…
PROXCYS downstream biosystems offer compact radial flow chromatography systems
In the less than 20 years since Marcel Raedts founded PROXCYS Downstream Biosystems B.V. in 2003, it has specialized in producing high-performance, low-pressure radial flow chromatography (HP-RFC) columns and systems. Applications of the HP-RFC columns and systems include purifying biologicals from a vareity of sources, including blood plasma, cell cultures and bacterial fermentation. Radial flow…
Morningside Pharmaceuticals donates 60,000 packs of medicine to Ukraine
The generic and branded pharmaceutical manufacturer Morningside Pharmaceuticals has donated roughly 60,000 medicine packs to support Ukrainian relief efforts. The donation will encompass 1.29 million doses of essential medicines. The Loughborough, UK–based company announced the donation after the company’s founder Dr. Nik Kotecha spoke with the Ukrainian Ambassador to the United Kingdom, Vadym Prystaiko. “The…
Equipment reliability is key to operational integrity in life sciences manufacturing
It’s difficult for a company to achieve excellence when batches are lost and maintenance crews must fight fires due to equipment failure. Still, solutions are available now to address these and other issues in the pharmaceutical industry. Most life sciences plants and facilities face many issues impacting reliability, throughput, and uptime. For example, a bioreactor’s…
A brief guide to Pharma 4.0 adoption
Pharma 4.0 projects may have gotten off to a slow start, but they have ramped up recently. Big Pharma has led the charge in deploying Pharma 4.0 projects, which involve the use of digital technology to draw operational efficiency. “It makes sense because a lot of these digital technologies have a big dollar sign with…
Roche to donate more medicines and diagnostics to Ukraine
With the war in Ukraine on the verge of entering its second month, Roche (SIX:RO, ROG; OTCQX:RHHBY) has announced that it will donate additional medications and diagnostics to the country. The company had announced its plans to aid the country in early March, which included 150,000 packs of the antibiotic Rocephin, an antibiotic WHO lists as…
How to improve quality assurance in the pharmaceutical industry
The pharmaceutical industry is expected to grow at an annual rate of 5-8% for the next three years. In just the past five years, a range of new technologies has been implemented to improve healthcare delivery, analytics and drug production. However, with the lingering challenges of COVID-19, the need for creative solutions has become more…
Pfizer donates Russian profits to Ukraine
Pfizer (NYSE: PFE) announced that it would redirect all profits from its Russian subsidiary to relief efforts in Ukraine. Concluding that pausing shipments of medicines to Russia would be counter to its principles, Pfizer had already decided to offer humanitarian efforts to Ukraine. Pfizer also announced that it would refrain from launching new clinical trials…